Home
>
National Drug Code (NDC)
>
LOVASTATIN
LOVASTATIN - 16590-311-60 - (LOVASTATIN)
Drug Information of LOVASTATIN
| Product NDC: | 16590-311 |
| Proprietary Name: | LOVASTATIN |
| Non Proprietary Name: | LOVASTATIN |
| Active Ingredient(s): | 10 mg/1 & nbsp; LOVASTATIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LOVASTATIN
| Product NDC: | 16590-311 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078296 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071101 |
Package Information of LOVASTATIN
| Package NDC: | 16590-311-60 |
| Package Description: | 60 TABLET in 1 BOTTLE, PLASTIC (16590-311-60) |
NDC Information of LOVASTATIN
| NDC Code | 16590-311-60 |
| Proprietary Name | LOVASTATIN |
| Package Description | 60 TABLET in 1 BOTTLE, PLASTIC (16590-311-60) |
| Product NDC | 16590-311 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LOVASTATIN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071101 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | LOVASTATIN |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
